Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy

Update Il y a 3 ans
Reference: NCT00911911

Woman Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The scope of the trial is to identify proteomic signatures correlated with tumor response to neo-adjuvant chemotherapy.


Inclusion criteria

  • Breast Cancer

Links